Moderna shares pop 7% after Cowen upgrades stock, saying it ‘will be a leader’ in RSV vaccines

Hits: 9

Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will “be a leader” in the RSV vaccine market.  Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


2 × one =